Interactions between the juxtamembrane domain of the EGFR and calmodulin measured by surface plasmon resonance
- PMID: 12359306
- DOI: 10.1016/s0898-6568(02)00034-7
Interactions between the juxtamembrane domain of the EGFR and calmodulin measured by surface plasmon resonance
Abstract
One early response to epidermal growth factor receptor (EGFR) activation is an increase in intracellular calcium. We have used surface plasmon resonance (SPR) to study real-time interactions between the intracellular juxtamembrane (JM) region of EGFR and calmodulin. The EGFR-JM (Met(644)-Phe(688)) was expressed as a GST fusion protein and immobilised on a sensor chip surface. Calmodulin specifically interacts with EGFR-JM in a calcium-dependent manner with a high on and high off rate. Chemical modification of EGFR-JM by using arginine-selective phenylglyoxal or deletion of the basic segment Arg(645)-Arg(657) inhibits the interaction. Phosphorylation of EGFR-JM by protein kinase C (PKC) or glutamate substitution of Thr(654) inhibits the interaction, suggesting that PKC phosphorylation electrostatically interferes with calmodulin binding to basic arginine residues. Calmodulin binding was also inhibited by suramin. Our results suggest that EGFR-JM is essential for epidermal growth factor (EGF)-mediated calcium-calmodulin signalling and for signal integration between other signalling pathways.
Copyright 2002 Elsevier Science Inc.
Similar articles
-
Phosphorylation of Thr654 but not Thr669 within the juxtamembrane domain of the EGF receptor inhibits calmodulin binding.Biochem Biophys Res Commun. 2006 Aug 25;347(2):381-7. doi: 10.1016/j.bbrc.2006.05.200. Epub 2006 Jun 9. Biochem Biophys Res Commun. 2006. PMID: 16793002
-
Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19238-43. doi: 10.1073/pnas.0703854104. Epub 2007 Nov 27. Proc Natl Acad Sci U S A. 2007. PMID: 18042729 Free PMC article.
-
The human epidermal growth factor receptor contains a juxtamembrane calmodulin-binding site.Biochemistry. 1998 Jan 6;37(1):227-36. doi: 10.1021/bi971765v. Biochemistry. 1998. PMID: 9425043
-
Targeting the calmodulin-regulated ErbB/Grb7 signaling axis in cancer therapy.J Pharm Pharm Sci. 2013;16(2):177-89. doi: 10.18433/j3v59v. J Pharm Pharm Sci. 2013. PMID: 23958188 Review.
-
Computational modeling of the EGF-receptor system: a paradigm for systems biology.Trends Cell Biol. 2003 Jan;13(1):43-50. doi: 10.1016/s0962-8924(02)00009-0. Trends Cell Biol. 2003. PMID: 12480339 Review.
Cited by
-
CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma.Cancer Cell Int. 2021 Feb 18;21(1):121. doi: 10.1186/s12935-021-01801-6. Cancer Cell Int. 2021. PMID: 33602237 Free PMC article.
-
Regulation of the ligand-dependent activation of the epidermal growth factor receptor by calmodulin.J Biol Chem. 2012 Jan 27;287(5):3273-81. doi: 10.1074/jbc.M111.317529. Epub 2011 Dec 8. J Biol Chem. 2012. PMID: 22157759 Free PMC article.
-
Regulation of ErbB Receptors by the Ca2+ Sensor Protein Calmodulin in Cancer.Biomedicines. 2023 Feb 22;11(3):661. doi: 10.3390/biomedicines11030661. Biomedicines. 2023. PMID: 36979639 Free PMC article. Review.
-
Epidermal growth factor receptors: function modulation by phosphorylation and glycosylation interplay.Mol Biol Rep. 2009 Apr;36(4):631-9. doi: 10.1007/s11033-008-9223-6. Epub 2008 Mar 14. Mol Biol Rep. 2009. PMID: 18340549
-
In vitro activation and inhibition of recombinant EGFR tyrosine kinase expressed in Escherichia coli.ScientificWorldJournal. 2013 Sep 25;2013:807284. doi: 10.1155/2013/807284. eCollection 2013. ScientificWorldJournal. 2013. PMID: 24187524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous